Anna-Maija Tolppanen

I have multidisciplinary background (MSc in bioinformatics, PhD in genetic epidemiology and >15 years’ experience in different fields and application areas of epidemiology since completing my PhD. My current research focusses on pharmacoepidemiology and clinical epidemiology.

The overarching aim of my research is to develop and implement methods and approaches for evaluating effectiveness and safety of treatments by using real-world data. The applied data ranges from national register-based studies to multi- and single-center studies using data from electronic medical records and medical reports as well as data collected specifically for research purposes.

My group has produced internationally recognized real-world evidence on utilisation and outcomes of different treatments, compared and validated different patient-reported outcome measurements and determined clinically important threshold values for them, and evaluated health inequalities in neurodegenerative disorders.

My research has been funded by e.g Academy of Finland research fellowship, 3x grants from Michael J Fox Foundation for Parkinson’s research, work package leadership in Horizon-EU funded project Real4Reg https://www.real4reg.eu/ coordinated by the German Medicines Agency.